BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 21050937)

  • 1. Design and use of constitutively active STAT5 constructs.
    Farrar MA
    Methods Enzymol; 2010; 485():583-96. PubMed ID: 21050937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constitutively active STAT5 constructs.
    Heltemes-Harris LM; Farrar MA
    Methods Mol Biol; 2013; 967():225-32. PubMed ID: 23296733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutively active STAT5A and STAT5B in vitro and in vivo: mutation of STAT5 is not a frequent cause of leukemogenesis.
    Yamada K; Ariyoshi K; Onishi M; Miyajima A; Hayakawa F; Towatari M; Saito H; Oka Y; Asano S; Nosaka T; Kitamura T
    Int J Hematol; 2000 Jan; 71(1):46-54. PubMed ID: 10729993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental effects.
    Gallego MI; Binart N; Robinson GW; Okagaki R; Coschigano KT; Perry J; Kopchick JJ; Oka T; Kelly PA; Hennighausen L
    Dev Biol; 2001 Jan; 229(1):163-75. PubMed ID: 11133161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous, bidirectional inhibitory crosstalk between PPAR and STAT5b.
    Shipley JM; Waxman DJ
    Toxicol Appl Pharmacol; 2004 Sep; 199(3):275-84. PubMed ID: 15364543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression and forced activation of stat5 in mammary gland of transgenic mice promotes cellular proliferation, enhances differentiation, and delays postlactational apoptosis.
    Iavnilovitch E; Groner B; Barash I
    Mol Cancer Res; 2002 Nov; 1(1):32-47. PubMed ID: 12496367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells.
    Moore MA; Dorn DC; Schuringa JJ; Chung KY; Morrone G
    Exp Hematol; 2007 Apr; 35(4 Suppl 1):105-16. PubMed ID: 17379095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of STAT5B phosphorylation correlating with expression of cytokine-inducible SH2-containing protein (CIS).
    Cooper JC; Boustead JN; Yu CL
    Cell Signal; 2006 Jun; 18(6):851-60. PubMed ID: 16125365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of a carboxy terminally truncated Stat5 with no transactivation domain in the mammary glands of transgenic mice inhibits cell proliferation during pregnancy, delays onset of milk secretion, and induces apoptosis upon involution.
    Iavnilovitch E; Eilon T; Groner B; Barash I
    Mol Reprod Dev; 2006 Jul; 73(7):841-9. PubMed ID: 16596634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A constitutively active Lck kinase promotes cell proliferation and resistance to apoptosis through signal transducer and activator of transcription 5b activation.
    Shi M; Cooper JC; Yu CL
    Mol Cancer Res; 2006 Jan; 4(1):39-45. PubMed ID: 16446405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degradation of STAT5 proteins in 3T3-L1 adipocytes is induced by TNF-{alpha} and cycloheximide in a manner independent of STAT5A activation.
    Floyd ZE; Segura BM; He F; Stephens JM
    Am J Physiol Endocrinol Metab; 2007 Feb; 292(2):E461-8. PubMed ID: 16985255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of the STAT5 signaling pathway in the regulation of mouse preimplantation development.
    Nakasato M; Shirakura Y; Ooga M; Iwatsuki M; Ito M; Kageyama S; Sakai S; Nagata M; Aoki F
    Biol Reprod; 2006 Oct; 75(4):508-17. PubMed ID: 16775227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGF modulates expression of STAT5 in mammary epithelial cells.
    Petersen H; Haldosén LA
    Exp Cell Res; 1998 Sep; 243(2):347-58. PubMed ID: 9743594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tel/PDGFRbeta induces stem cell differentiation via the Ras/ERK and STAT5 signaling pathways.
    Dobbin E; Graham C; Corrigan PM; Thomas KG; Freeburn RW; Wheadon H
    Exp Hematol; 2009 Jan; 37(1):111-121. PubMed ID: 19100521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Roles of STAT5 in hematopoietic regulation and blood diseases].
    Zhao YZ; Yuan WP; Cheng T
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1496-500. PubMed ID: 23257461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential function of STAT5 isoforms in head and neck cancer growth control.
    Leong PL; Xi S; Drenning SD; Dyer KF; Wentzel AL; Lerner EC; Smithgall TE; Grandis JR
    Oncogene; 2002 Apr; 21(18):2846-53. PubMed ID: 11973644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Forced activation of Stat5 subjects mammary epithelial cells to DNA damage and preferential induction of the cellular response mechanism during proliferation.
    Eilon T; Barash I
    J Cell Physiol; 2011 Mar; 226(3):616-26. PubMed ID: 20717961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptor gamma regulates expression of signal transducer and activator of transcription 5A.
    Olsen H; Haldosén LA
    Exp Cell Res; 2006 May; 312(8):1371-80. PubMed ID: 16457814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naturally occurring dominant-negative Stat5 suppresses transcriptional activity of estrogen receptors and induces apoptosis in T47D breast cancer cells.
    Yamashita H; Iwase H; Toyama T; Fujii Y
    Oncogene; 2003 Mar; 22(11):1638-52. PubMed ID: 12642867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enforced activation of STAT5A facilitates the generation of embryonic stem-derived hematopoietic stem cells that contribute to hematopoiesis in vivo.
    Schuringa JJ; Wu K; Morrone G; Moore MA
    Stem Cells; 2004; 22(7):1191-204. PubMed ID: 15579639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.